Sangamo's stock price is surging after a pair of patients reported no bleeding events for as long as 24 weeks following treatment following investigational SB-525 gene therapy for severe hemophilia A.

Shares of Spark Therapeutics slide amid a second regulatory-related delay of its $4.3 billion deal with Swiss pharmaceuticals group Roche Holdings AG.

Roche plans to regroup on its $4.3 billion offer to buy Spark Therapeutics after failing to win enough Spark shareholder votes, or receiving U.S. regulatory approval.

Roku was hit with a pair of downgrades on Wednesday

Jim Cramer asks whether there aren't enough good things happening that we can sustain an advance without a China deal.

ETFs could see big inflows again and Sparks stock soars; these are among the important market items today.

The Dow Jones Industrial Average rose modestly Monday after Donald Trump said he will delay increasing tariffs on China-made goods.

Spark Therapeutics shares more than double Monday after the gene therapy specialist agreed to a $4.3 billion takeover by Switzerland-based Roche Holding, the world's biggest maker of cancer treatments.

U.S. stock futures rise after Donald Trump says he will delay increasing tariffs on China-made goods; Swiss drug giant Roche to buy Spark Therapeutics for about $4.8 billion; Warren Buffett wants to make an 'elephant-sized acquisition'; Kraft Heinz reportedly reviewing options for Maxwell House.

"We believe we have plenty of room on price value," Disney CEO Bob Chapek said of the group's streaming price hikes. "And we do not believe that there's going to be any meaningful on our churn as a result."

The theme park giant has been trying to make changes and that has caused some issues for its guests.

The pizza giant goes someplace pizza fans may not want to follow but Domino's, Pizza Hit, and Little Caesars don't sell this.